Given the paradigm that the myeloid compartment may contribute to colorectal cancer (CRC) progression through its inflammatory and immunosuppressive properties (27), we next asked whether Nod2 signaling in myeloid cells could intrinsically regulate tumor progression in the colitis-associated carcinogenesis model. The gene discussed is NOD2; the disease is colorectal cancer.